And just in case you didn't get it, Azer-cel is an Allogeneic CAR T. The FDA statement is relating to Autologous.
Secondly, I would suggest that if Azer-cel in combo with Oncarlytics proves effective, its market won't be limited to DLBCL relapse patients. Maybe do some reading up on that
.
Why IMU is a multi multi bagger, page-26520
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.7¢ | $1.172M | 24.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 2127742 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.8¢ | 2570892 | 25 |
View Market Depth
| Last trade - 11.11am 27/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |